TOP > News Release > list in 2007
News Release

New Release Browse by Year

2007 News Release

RSS
Back Number
2008
2007
2006
2005
Browse by Category
Corporate
R&D
Products
Others
Guide to Category Symbols
Corporate
R&D
Products
Others
2007.12.21：
DAIICHI SANKYO to Dissolve Subsidiary
2007.12.21：
DAIICHI SANKYO Announces Merger of Subsidiaries
2007.11.30：
Share Transfer of NIPPON NYUKAZAI and SINO-JAPAN CHEMICAL
(subsidiaries of DAIICHI SANKYO)
2007.11.04：
In Landmark Phase III Head-to-Head Study, Prasugrel Statistically
Superior to Clopidogrel in Reducing Risk of Heart Attack
2007.11.04：
Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel
2007.10.26：
DAIICHI SANKYO Announces the Revisions of Financial Forecasts for FY2007
2007.10.25：
Study Protocols Will be Amended in Two Small Early-Phase Prasugrel Studies
2007.10.01：
DAIICHI SANKYO EUROPE is applying for approval of its new
combination product of Olmesartan and Amlodipin
2007.09.28：
Application Filed for Additional Indication for Selective Antithrombin Agents Novastan(R) HI Injection 10mg/2mL and Slonnon(R) HI Injection 10mg/2mL for Heparin-Induced Thrombocytopenia
2007.09.28：
AZOR(TM) Receives FDA Approval for Treatment of High Blood Pressure
2007.08.29：
Deal for Irinotecan Hydrochloride with Yakult Honsha Terminates
2007.08.28：
Additional Pediatric Indication for Fentanyl Injection Approved
Japan's First Ever Approval of Physician-led Clinical Trial
2007.08.22：
Daiichi Sankyo and Forest Laboratories Sign Letter of Intent for Co-Promotion of AZOR(TM)
2007.07.31：
DAIICHI SANKYO Announces Results of Share Buyback
2007.07.12：
Fifth Sankyo Takamine Memorial Award Announced
2007.07.12：
Amgen Grants Daiichi Sankyo Exclusive Rights to Develop and
Commercialize Denosumab in Japan
2007.06.26：
DAIICHI SANKYO COMMENCES PATENT LITIGATION AGAINST MYLAN IN THE UNITED STATES
2007.06.14：
Canadian Levofloxacin Patent Upheld by Federal Appeal Court
2007.06.01：
DAIICHI SANKYO to Acquire Own Shares
2007.05.25：
DAIICHI SANKYO to award stock options as remuneration
2007.05.22：
Amlodipine and Olmesartan Study Results Released;
Late Breaker Presented at American Society of Hypertension
Twenty-Second Annual Scientific Meeting (ASH 2007)
First Release of Data for New Combination
2007.05.15：
DAIICHI SANKYO COMPANY Announces Executive-Change Candidates
2007.05.14：
Announce on NDA Submission for Injectafer(R)
2007.05.08：
Consolidated forecast for FY2007
2007.04.27：
Revisions of Earnings Forecasts for FY 2006
2007.04.23：
Daiichi Sankyo to Transfer all Daiichi Fine Chemical Shares to Kyowa Hakko
2007.04.23：
Daiichi Sankyo to Transfer All Shares of Saitama Daiichi Pharmaceutical
2007.04.20：
Launch of New Package (0.8-g sachet) of Zyrtec(R) Dry Syrup 1.25% selective H1 receptor antagonist,anti-allergic agent
2007.04.18：
Completion of Phase I Trial on the Anti-influenza Drug CS-8958
2007.04.02：
The transfer of all commercial rights for Panaldine(R)
Back Number
2008
2007
2006
2005
Browse by Category
Corporate
R&D
Products
Others